Lawmakers halt push for drug prices in TV ads
In an effort to get the first set of FY 2019 appropriations bills to the President’s desk, US House leaders scrapped a bipartisan amendment that would have required drugmakers to include list prices in direct-to-consumer (DTC) television ads.
The amendment — sponsored by Sens. Dick Durbin (D-IL) and Chuck Grassley (R-IA) — was offered and subsequently withdrawn during a joint conference committee of the House and Senate, despite passing the Senate last month. The move was followed by finger pointing.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.